Issue 11, 2014

A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery

Abstract

Here we introduce a proteomics methodology based on nanoliquid-chromatography tandem mass spectrometry (nanoLC/MS-MS) to investigate the “protein corona effect for targeted drug delivery”, an innovative strategy, which exploits the “protein corona” that forms around nanoparticles in a physiological environment to target cells.

Graphical abstract: A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
14 May 2014
Accepted
05 Aug 2014
First published
05 Aug 2014

Mol. BioSyst., 2014,10, 2815-2819

Author version available

A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery

D. Pozzi, G. Caracciolo, A. L. Capriotti, C. Cavaliere, S. Piovesana, V. Colapicchioni, S. Palchetti, A. Riccioli and A. Laganà, Mol. BioSyst., 2014, 10, 2815 DOI: 10.1039/C4MB00292J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements